A detailed history of Xtx Topco LTD transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 23,625 shares of CODX stock, worth $29,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,625
Previous 18,978 24.49%
Holding current value
$29,531
Previous $25,000 4.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.06 - $1.42 $4,925 - $6,598
4,647 Added 24.49%
23,625 $26,000
Q4 2023

Feb 13, 2024

SELL
$1.0 - $1.5 $2,785 - $4,177
-2,785 Reduced 12.8%
18,978 $25,000
Q3 2023

Nov 13, 2023

BUY
$1.03 - $1.85 $22,415 - $40,261
21,763 New
21,763 $23,000
Q3 2022

Nov 14, 2022

SELL
$2.87 - $7.01 $40,883 - $99,857
-14,245 Reduced 56.29%
11,060 $36,000
Q2 2022

Aug 15, 2022

BUY
$3.76 - $6.29 $95,146 - $159,168
25,305 New
25,305 $142,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $42.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.